Thai Guideline for Nuclear Medicine Investigations of Neurocognitive Disorders: Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and Thai Medical Physicist Society Collaboration

dc.contributor.authorKaewchur T.
dc.contributor.authorThientunyakit T.
dc.contributor.authorChamroonrat W.
dc.contributor.authorKhiewvan B.
dc.contributor.authorKiatkittikul P.
dc.contributor.authorWongsurawat N.
dc.contributor.authorChotipanich C.
dc.contributor.authorLikitjaroen Y.
dc.contributor.authorSenanarong V.
dc.contributor.authorPasawang P.
dc.contributor.authorSontrapornpol T.
dc.contributor.authorPoon-iad N.
dc.contributor.authorAmnuaywattakorn S.
dc.contributor.authorTepmongkol S.
dc.contributor.correspondenceKaewchur T.
dc.contributor.otherMahidol University
dc.date.accessioned2024-12-08T18:17:37Z
dc.date.available2024-12-08T18:17:37Z
dc.date.issued2024-11-01
dc.description.abstractNuclear medicine investigations play a significant role in diagnosing dementia, mainly using imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT). By providing functional and molecular data via brain imaging, nuclear medicine investigations offer valuable insights that complement clinical evaluations and structural imaging in the early detection, diagnosis, and differentiation of various types of dementia, leading to more accurate diagnosis and personalized treatment planning. Therefore, the Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and the Thai Medical Physicist Society have collaborated to establish these practical nuclear medicine investigation guidelines aiming to (1) identify the role of nuclear medicine studies in patients with neurocognitive disorders; (2) assist referrers in requesting the most appropriate procedure for diagnosis of each type of neurocognitive disorders; and (3) identify scientific evidence that is useful to assisting nuclear medicine professionals in recommending, performing, interpreting, and reporting the results of nuclear medicine investigations in patients with neurocognitive disorders.
dc.identifier.citationDiagnostics Vol.14 No.22 (2024)
dc.identifier.doi10.3390/diagnostics14222474
dc.identifier.eissn20754418
dc.identifier.scopus2-s2.0-85210556354
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/102313
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.titleThai Guideline for Nuclear Medicine Investigations of Neurocognitive Disorders: Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and Thai Medical Physicist Society Collaboration
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85210556354&origin=inward
oaire.citation.issue22
oaire.citation.titleDiagnostics
oaire.citation.volume14
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationFaculty of Medicine, Chiang Mai University
oairecerif.author.affiliationFaculty of Medicine, Khon Kaen University
oairecerif.author.affiliationChulabhorn Royal Academy
oairecerif.author.affiliationKing Chulalongkorn Memorial Hospital
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University
oairecerif.author.affiliationFaculty of Medicine, Chulalongkorn University

Files

Collections